reNEW Melbourne Associate Investigator Dr Holly Voges and her team have created the world’s first three-dimensional human heart valve tissue from stem cells, paving the way for new treatments for heart valve disease.
Bringing together research excellence to harness the therapeutic potential in stem cell medicine
Melissa Little
Professor and CEO
reNEW – a unique global research center in stem cell medicine
reNEW is an international consortium of three leading research institutions in Denmark, Australia and the Netherlands, led by renowned Professor and CEO Melissa Little. We strive to advance a new generation of effective and safe stem cell-based therapies, built on a global collaborative network of excellence in targeted biomedical research.
Our mission is to develop an international targeted research center to deliver innovative stem cell driven therapies to transform the lives of people with incurable disease
Translating research into new stem cell medicine
The aim of the center is to strengthen the pathway from stem cell discovery research to clinical outcomes. We will apply our understanding of stem cells to improve drug development and deliver novel cell and tissue therapies.
Meet our leading scientists
Leading scientists from around the globe collaborate to transform the world of stem cell medicine
Understanding stem cells and how they can be used
A stem cell can renew itself and generate other cell types. We all rely on stem cells to exist and to survive. Understanding stem cells and their potential has long been of interest to researchers across the globe. Stem cell medicine refers to the application of that understanding to accelerate the development of new therapies for people living with incurable diseases.
Be part of transformative science
Join us in delivering the next generation of effective and safe stem cell-based therapies. reNEW is situated in three places – Copenhagen, Leiden and Melbourne. But no matter where in the world you are, you can help us transform the future of stem cell medicine.
Impacting the world with our science
Find out the latest in the world of stem cell medicine.
A gradient of opposing signals regulates embryonic development
A reNEW team led by Pascale Dijkers and Niels Geijsen discovered how a gradient of two signaling molecules dictates cellular composition and elongation in gastruloids.
Beyond approval: ensuring the future of ATMPs
Nearly half of currently marketed ATMPs will lose their regulatory market exclusivity period by 2030. This raises the question how to ensure persistent patient access to these often life-changing therapies
